Biora Therapeutics, Inc. (BIOR)

Biora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	10.82	15.21	30.49	88.4	92.08	33.04
Cash & Cash Equivalents	10.82	15.21	30.49	88.4	92.08	33.04
Cash Growth	-64.48%	-50.10%	-65.51%	-4.00%	178.66%	-52.25%
Receivables	0	0	0	0.65	6.63	22.19
Inventory	0	0	0	0	0	10.94
Other Current Assets	3.25	3.86	7.63	9.73	27.63	8.48
Total Current Assets	14.07	19.07	38.12	98.78	126.34	74.65
Property, Plant & Equipment	2.55	2.77	3.14	3.67	8.11	15.89
Goodwill and Intangibles	6.07	6.07	6.07	6.07	6.07	10.99
Other Long-Term Assets	0.29	3.3	6.2	0.33	13.92	0.2
Total Long-Term Assets	8.92	12.14	15.41	10.06	28.1	27.08
Total Assets	22.99	31.22	53.53	108.84	154.44	101.73
Accounts Payable	4.94	2.84	3.61	8.71	17.38	15.75
Current Debt	1.98	1.98	0	0.01	0.34	0.97
Other Current Liabilities	44.19	58.15	19.7	52.89	54.95	83.62
Total Current Liabilities	51.1	62.97	23.31	61.61	72.67	100.34
Long-Term Debt	43.28	43.74	127.81	126.39	160.2	72.41
Other Long-Term Liabilities	28.79	25.93	4.7	5.81	28.56	12.86
Total Long-Term Liabilities	72.07	69.66	132.51	132.21	188.76	85.26
Total Liabilities	123.18	132.64	155.81	193.82	261.43	185.6
Total Debt	45.25	45.71	127.81	126.4	160.54	73.37
Debt Growth	-64.70%	-64.23%	1.11%	-21.26%	118.80%	0.87%
Retained Earnings	-955.15	-950.96	-826.84	-788.69	-541.27	-348.48
Shareholders' Equity	-100.19	-101.42	-102.29	-84.98	-106.99	-83.87
Net Cash / Debt	-34.43	-30.5	-97.33	-38.01	-68.47	-40.33
Net Cash Per Share	-1.18	-1.93	-12.75	-9.88	-62.21	-206.50
Working Capital	-37.03	-43.9	14.81	37.17	53.67	-25.69
Book Value Per Share	-3.42	-6.43	-13.40	-22.09	-97.22	-429.45

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).